Skip to main content

Accuracy of and preferences for blood-based versus oral-fluid-based HIV self-testing in Malawi: a cross-sectional study



HIV self-testing (HIVST) can use either oral-fluid or blood-based tests. Studies have shown strong preferences for self-testing compared to facility-based services. Despite availability of low-cost blood-based HIVST options, to date, HIVST implementation in sub-Saharan Africa has largely been oral-fluid-based. We investigated whether users preferred blood-based (i.e. using blood sample derived from a finger prick) or oral fluid-based HIVST in rural and urban Malawi.


At clinics providing HIV testing services (n = 2 urban; n = 2 rural), participants completed a semi-structured questionnaire capturing sociodemographic data before choosing to test using oral-fluid-based HVST, blood-based HIVST or provider-delivered testing. They also completed a self-administered questionnaire afterwards, followed by a confirmatory test using the national algorithm then appropriate referral. We used simple and multivariable logistic regression to identify factors associated with preference for oral-fluid or blood-based HIVST.


July to October 2018, N = 691 participants enrolled in this study. Given the choice, 98.4% (680/691) selected HIVST over provider-delivered testing. Of 680 opting for HIVST, 416 (61.2%) chose oral-fluid-based HIVST, 264 (38.8%) chose blood-based HIVST and 99.1% (674/680) reported their results appropriately. Self-testers who opted for blood-based HIVST were more likely to be male (50.3% men vs. 29.6% women, p < 0.001), attending an urban facility (43% urban vs. 34.6% rural, p = 0.025) and regular salary-earners (49.5% regular vs. 36.8% non-regular, p = 0.012). After adjustment, only sex was found to be associated with choice of self-test (adjusted OR 0.43 (95%CI: 0.3–0.61); p-value < 0.001). Among 264 reporting blood-based HIVST results, 11 (4.2%) were HIV-positive. Blood-based HIVST had sensitivity of 100% (95% CI: 71.5–100%) and specificity of 99.6% (95% CI: 97.6–100%), with 20 (7.6%) invalid results. Among 416 reporting oral-fluid-based HIVST results 18 (4.3%) were HIV-positive. Oral-fluid-based HIVST had sensitivity of 88.9% (95% CI: 65.3–98.6%) and specificity of 98.7% (95% CI: 97.1–99.6%), with no invalid results.


Offering both blood-based and oral-fluid-based HIVST resulted in high uptake when compared directly with provider-delivered testing. Both types of self-testing achieved high accuracy among users provided with a pre-test demonstration beforehand. Policymakers and donors need to adequately plan and budget for the sensitisation and support needed to optimise the introduction of new quality-assured blood-based HIVST products.


Global (95–95-95) targets are that by 2025, 95% of all people living with the Human Immunodeficiency Virus (HIV) will know their HIV status, 95% of all people with diagnosed HIV infection are on sustained HIV treatment and, 95% of all people on treatment are virally suppressed [1]. HIV self-testing (HIVST) is recommended as a safe, acceptable and effective approach to increase access to and uptake of HIV testing [2,3,4,5,6,7].

Studies from a wide range of countries have established that HIVST is highly acceptable and accurate among various population groups [8,9,10,11,12,13,14,15,16,17,18,19,20,21]. Within sub-Saharan Africa, HIVST is becoming increasingly important in reaching the remaining 12% of people with HIV who are still unaware of their status [22]. Currently, 79% of countries in the region have HIVST policies, however only 45% of these countries are fully implementing [23]. To scale up HIVST implementation further, it is essential that quality-assured and affordable products are available alongside strengthened supply chain systems and increased user awareness [24].

Both blood-based self-testing (BBST) (i.e. using blood sample derived from a finger prick) and oral-fluid-based self-testing (OFBST) have been found to be accurate and acceptable particularly with demonstrations and training before self-testing for the first time in sub-Saharan Africa [25], and there are now five blood-based products and one oral-fluid-based product for HIVST which are prequalified by the World Health Organization [26]. There are perceived advantages and disadvantages of either method. For example, OFBST is widely viewed as simple, painless, quick and less invasive [27, 28], but characterised by lower sensitivity [12, 24]. BBST is perceived as more accurate [27] and having a higher sensitivity [24], but more invasive and complex to perform [29]. Despite the availability of several different (blood-based) products, some of which cost as low as $1.00, most HIVST implementation to date has been oral-fluid-based owing to the simple nature of the oral fluid-based HIVST kits, despite their higher minimum cost of $2.50. Wide-scale implementation of blood-based HIVST in sub-Saharan Africa is hampered by many bottlenecks including lack of quality-assured products, supply chain issues and lack of awareness among potential users [15, 19].

Here, we report on a cross-sectional study investigating preference for oral-fluid or blood-based HIVST and the accuracy of HIVST results, based on the results which untrained participants reported after conducting their own testing, in a real-world setting. We also explored reasons for accepting HIVST and participants’ preferences for oral-fluid and blood-based HIVST among people attending rural and urban facilities in Malawi.


Study design, setting and participants

We conducted the cross-sectional study at four facilities (n = 2 urban; n = 2 rural) offering HIV testing services in Blantyre, Malawi. Participants were eligible for the study if they were ≥ 16 years old and not already aware to be HIV positive.

Study procedures

Clients seeking HIV testing services at the four facilities were approached by the facility healthcare provider and, after consenting to participate, directed to the study counsellor. Consenting participants completed a short interviewer-administered questionnaire which captured sociodemographic data. Participants then chose one of three HIV testing options: oral-fluid-based HIVST, blood-based HIVST or provider-delivered blood-based testing. Regardless of choice of testing method, all participants received testing within the health facility of their original attendance, where they either self-tested in a private space or, if they chose provider-delivered testing, were tested by a HIV provider with no additional study follow-up.

Those that opted for self-testing (either type) were asked to select a statement that best described their reason for choosing that testing modality. Each participant was then shown a brief pre-test demonstration specific to the self-test type they had chosen (BBST ~ 5–8 min, OFBST ~ 2 min). Participants were also provided with written and pictorial instructions which they could check whilst self-testing. After self-testing without direct assistance from a provider, individuals then completed a simple form on which they ticked one of three options: HIV negative, HIV positive or not sure/invalid. The used self-test device was then collected by a health worker and the result re-read within 40 min of self-testing by the participant. The health worker recorded the ‘re-read result’ whilst unaware of the result which the participant had recorded. Options here differed slightly and were: negative, faint positive, clear positive and invalid.

For those clients who self-tested, the health worker performed confirmatory testing using both Determine and Unigold finger-prick rapid tests (national testing algorithm in Malawi) in parallel and recorded the results. Afterwards, they administered a questionnaire which asked participants about both their experience and perspective of HIVST. Appropriate referral was carried out by the health worker for any positive results with HIVST.

Testing methods

Self-testing used OraQuick HIV Self-test (OraSure Technologies Inc., Bethlehem, PA, USA) run using oral-fluid specimens and INSTI HIV Self-test (BioLytical® Laboratories Inc., Richmond, B.C., Canada) run from finger-prick specimens. For reference, the manufacturer-reported sensitivity and specificity are 99.3% and 99.8%, respectively for the OraQuick test and 99.8% and 99.5% for INSTI (using finger-prick blood) (

Corresponding with the concurrent national HIV testing algorithm in Malawi at the time, Determine (Abbott Laboratories) and Unigold (Trinity Biotech plc) rapid diagnostic tests were also performed on finger-prick blood.

Outcomes and measurements

Accuracy of self-read HIV self-test results

The main outcomes were the sensitivity and specificity of blood-based and oral-fluid-based self-tests, with respect to the participant-reported result. Accuracy (sensitivity and specificity) was assessed by comparing results with (a gold standard of) the national testing algorithm in Malawi (Determine and Unigold). If required, participants received further testing at the health facility of their original attendance in accordance with the national algorithm for discrepant results.

Sociodemographic characteristics

The interviewer selected either ‘Yes,’ ‘No’ or one option from a list in answer to questions about each participant’s sociodemographic status.

Reasons for opting for self-test type

Clients selected a statement that best described their reason for choosing that testing modality.

Post-test questionnaire outcomes

Clients’ experience of HIVST: Clients selected from lists of options to describe who was present when they self-tested, whether and to whom they disclosed their result, whether they had any regrets about self-testing and what actions they took afterwards.

Clients’ perspective on HIVST: Clients selected from lists of options to describe how confident they were that their result was accurate and which combination of test type and setting they would prefer for their next HIV test.

Statistical methods/analyses

Data were stored in a SQL database, encoded and analysed using Stata version 16 (College Station, Texas, USA). Only participants who proceeded with HIV testing were included in the analysis. Participants who selected the incorrect self-test type when asked which they had used were excluded from the post-test questionnaire analysis.

Descriptive analysis

Using data from the sociodemographic questionnaire, variables describing sociodemographic characteristics were cross-tabulated by chosen HIV test type and column percentages calculated. For comparisons of categorical and continuous data, percentages and means were used, respectively. Missing data were evaluated for each variable by computing the proportion missing, with the denominator as the total number of participants who agreed to test, and the numerator being the total with a missing response.

To describe the reasons why clients opted for a test type, the proportions of clients selecting each particular reason from the list of available options were estimated. Proportions were compared as percentages by self-test type.

Analysis of factors affecting self-test choice

A priori, the intended aim was specifically to compare factors associated with selecting blood-based versus oral-fluid-based self-test rather than provider-delivered blood-based testing versus (any) self-testing. Therefore, participants who opted for provider-delivered testing were excluded from this analysis. Proportions of participants selecting each self-test type (OFBST vs. BBST) were compared by each sociodemographic variable and, for the crude analysis, p-values were obtained by Χ2 tests for all variables except age (t-test). P-values of < 0.05 were regarded as significant. There was no adjustment for potential confounders in this analysis.

Analysis was also performed using multivariable logistic regression to estimate adjusted odds ratios and p-values for the relationship between choice of self-test type and selected variables. Variables were included as potential confounders in the adjusted model if they had been found to be associated with self-test choice based on Χ2 testing or if they were factors often stated in the literature to be associated. On this basis, we adjusted for age, sex, literacy, location, marital status and regular income.

Accuracy analysis

Sensitivity and specificity for each self-test type were estimated omitting any results reported as ‘not sure/invalid’ and reported as percentages (with 95% confidence intervals, CI). These were estimated using the ‘diagti’ command in Stata by inputting the numbers of true positives, false positives, true negatives and false negatives. For any false positives or false negatives, the self-read result was compared to the re-read result by the study health worker to determine whether these were reading errors or truly inaccurate test results.

Analysis of post-test questionnaire responses

For the post-test survey data, we conducted a descriptive analysis. Here we simply list proportions of users selecting each category in answer to questions on their experience of HIV self-testing and their perspective on it.


From July to October 2018, approximately 1,100 clients seeking HIV testing services at the four facilities were approached by the facility service provider, who then screened for eligibility and took consent. Of these, 709/1,100 (64% response rate) were eligible and initially consented to participate. All 709 completed the sociodemographic questionnaire, of which 18/709 (2.5%) answered the questions but then opted out of any type of HIV testing and so were excluded from the analysis. There were no missing data for any sociodemographic variables.

Of the remaining 691 who both completed the sociodemographic questionnaire and tested for HIV (any type), 680/691 (98.4%) opted for self-testing and only 11/691 (1.6%) opted not to self-test and therefore received only provider-delivered testing as standard of care. Of the 680 who self-tested, 679 (99.9%) completed the post-test questionnaire (1 was lost to follow-up). Of the 679, five (0.7%) mistakenly selected the wrong self-test type (2 who had used OFBST selected BBST; vice versa for 3 others). Therefore, these five responses were excluded from the post-test questionnaire analysis hence the final figure of 674 participants (n = 414 OFBST; n = 260 BBST) (Fig. 1).

Fig. 1
figure 1

Study flow diagram

Relatively equal numbers 349 (50.1%) and 342 (49.5%) were attending urban and rural health-care facilities, respectively. Over half (56.0%) were female, 52.1% were married and 45.4% were < 25 years. The overall mean age was 26.2 years (standard deviation 8.4). More than half (54.3%) had some secondary education or higher, 42.0% had some primary schooling and 3.8% had no formal schooling, with a majority of all participants (88.1%) reporting that they were literate (could read a one-page letter or newspaper in English or Chichewa). Overall, most (83.9%) did not receive a regular salary and again, most (87.4%) rated their own health to be at least good (Table 1).

Table 1 Sociodemographic characteristics, overall and by type of HIV test (N = 691)

Factors associated with choice of self-test type

Of the 680 participants opting for HIV self-testing, 416/680 (61.2%) chose oral-fluid-based HIVST and 264/680 (38.8%) chose blood-based HIVST. Table 2 shows the proportions of participants selecting each self-test type compared by various variables. Most women (266/378; 70.4%) opted for oral-fluid-based HIVST whilst about half of men (150/302; 49.7%) opted for this testing modality (p < 0.001). Participants testing in rural facilities frequently opted for oral-fluid-based HIVST (221/338; 65.4%) whilst those testing in urban facilities frequently chose blood-based HIVST (147/342; 43.0%) (p = 0.025). A greater proportion of illiterate participants opted for oral-fluid-based HIVST (70.0%; 56/80) than those who were literate (60.0%; 360/600) although this difference was not statistically significant p = 0.085.

Table 2 Factors associated with choice of self-test type (unadjusted analysis)

There was some evidence of an association between the receipt of a regular salary and choice of test; a greater proportion of participants not receiving a regular salary chose oral-fluid-based HIVST (63.2%; 361/571) compared to those with a regular salary (50.5%; 55/109) (p = 0.012). In the unadjusted analysis, type of self-test selected was not found to be associated with any of the remaining variables (Table 2).

Accuracy analysis

HIV prevalence among those participants who opted for self-testing was 4.3% (29/680) (Table 3).

Table 3 Accuracy of self-read HIV self-tests against gold standarda

Based on participant-reported results, the sensitivity of oral-fluid-based HIVST was 88.9% (16/18; 95% CI: 65.3–98.6%) and the specificity was 98.7% (393/398; 95% CI: 97.1–99.6%). No participants recorded ‘not sure/invalid’ with this test. There were five oral-fluid-based HIVST false positives, four of which the health worker had recorded on re-read as ‘faint positive’ and one of which was a reading error (recorded as negative on re-read). There were two oral-fluid-based HIVST false negatives, for which the re-read result agreed (also recorded as negative on re-read) (Table 3).

Based on participant-reported results, the sensitivity of blood-based HIVST was 100.0% (11/11; 95% CI: 71.5–100.0%) and the specificity was 99.6% (232/233; 95% CI: 97.6–100.0%). Twenty (7.6%; 20/264) results had been recorded as ‘not sure/invalid’ and were excluded from this calculation. For all of these, the re-read by the health worker was recorded as ‘invalid.’ The ‘gold-standard’ result for all these 20 was negative. The one false positive blood-based HIVST result was a reading error (recorded as negative on re-read) (Table 3).

Reasons for opting for self-testing type

Of the 416 clients who performed oral-fluid-based HIVST, data were missing for 12 (2.9%). Of the 264 who performed blood-based HIVST, data were missing for two (0.8%) for this part of the questionnaire. Among those who chose oral-fluid-based HIVST, the majority (76.5%; 309/404) reported that they had done so because it was ‘easier to use than the blood-based self-test’. Among those who chose blood-based HIVST, the most frequently selected reasons for doing so were ‘interested in new technologies’ (32.1%; 84/262) and ‘more accurate than the oral-fluid-based self-test’ (30.9%; 81/262) (Table 4).

Table 4 Reasons for opting for self-test type

Experiences and perspectives of self-testing – post-test survey

After excluding five participants who selected the incorrect self-test type (i.e. they ticked that they had done OFBST when in fact they had done BBST or vice versa), the analysis of questionnaire answers was conducted among 674 participants (414 OFBST; 260 BBST). Among these, 418/674 (62.0%) were alone when they tested and 256/674 (38.0%) had somebody else with them: 154/256 (60.2%) had a spouse/partner, 50/256 (19.5%) had another family member, 47/256 (18.4%) had a friend, 4/256 (1.6%) had a healthcare worker and one (0.4%) participant answered 'other'. 60.4% (407/674) reported disclosing their result to someone. Of these, 43.5% (177/407) disclosed to their partner/spouse. The remainder selected 'other' (28.0%; 114/407), 'other family member' (21.4%; 87/407), parent (6.4%; 26/407) or employer (0.7%; 3/407). Only a minority (3.0%; 20/674) felt regret having taken the test when asked to look back at it. Only three (0.4%) participants felt they were pressured to disclose their result to another person, one by a partner/spouse, one by a parent and one by 'other.'

In response to the question ‘What actions did you take after your last HIV test?’ 416/674 (68.4%) stated that they confirmed their self-test result, 11 (1.6%) indicated they went for HIV care (although only nine of these had tested positive on both self-test and Unigold/Determine), 88 (13.1%) got condoms and 123 (18.3%) reported that they ‘did not do anything.’ Of the 300 men included in the questionnaire, 54 (18.0%) reported deciding that they would like to have voluntary medical male circumcision (VMMC).

Most (90.2%; 608/674) reported that they were ‘very confident’ that their test result was accurate. The remainder were ‘somewhat confident’ (57/674; 8.5%) or ‘not very confident’ (9/674; 1.3%). From the available options for combination of test type and setting (in response to the question ‘Which would you most want to be your next HIV test?’), participants most frequently selected the option ‘blood-based self-testing without a counsellor present’ (243/674; 36.1%). The second most popular option was ‘oral-fluid-based self-testing without a counsellor present’ (236/674; 35.0%), followed by ‘oral-fluid-based self-testing with a counsellor present’ (141/674; 20.9%) in third place. The least popular options included ‘blood-based self-testing with a counsellor present’ (34/674; 5.0%), ‘testing by a counsellor at a hospital, clinic or health centre’ (19/674; 2.8%) and ‘testing by a counsellor at a mobile clinic’ (1/674; 0.2%). None selected the option ‘testing by a counsellor at home.’


We conducted a cross-sectional study to investigate the preference for blood-based versus oral fluid-based HIV self-testing among lay users attending rural and urban health facilities in Malawi. We also explored reasons for accepting self-testing and participants’ preferences for oral-fluid and blood-based HIVST. Overall, we found that with minimal pre-test demonstration, individuals could accurately self-test with either oral-fluid-based or blood-based kits. While preferences for both blood-based and oral-fluid-based HIVST were high compared to the traditional provider-delivered testing, oral-fluid-based HIVST was most preferred overall. These findings can inform future HIVST implementation and procurement planning.

Accuracy of participant-reported results was acceptable for both HIVST options and similar to previous studies [25], but highest for blood-based HIVST, which achieved 100% sensitivity and 100% specificity. The lower sensitivity of oral-fluid-based HIVST observed may have been driven by retesting among people on antiretroviral therapy, which can sometimes lead to false negative results [30, 31], but this was not fully assessed in this study. Despite otherwise good performance, users of blood-based HIVST had a higher rate of individuals reporting invalid results when compared with users of oral-fluid-based HIVST (7.6% vs. 0%). The exact causes of invalid results reported were unclear, but a previous systematic review found invalid results with blood-based HIVST were slightly higher than with oral-fluid-based HIVST [25]. Some of the key challenges were due to difficulty with sample collection and transfer steps. Further, since we observed that providers also made errors when reading blood-based HIVST results, it is possible that overall, individuals—both clients and providers, were less familiar with these new test kits and more training and demonstration was needed. Since we did not conduct further testing on inconclusive or discrepant results, we could not rule out that individuals with known HIV status on antiretroviral therapy could have been included.

At the time of the study, providers and self-testers were likely to have been much more familiar with oral-fluid-based HIVST, which has been implemented in Malawi since 2011. Early studies with oral-fluid-based HIVST did report higher rates of invalids, such as in Kenya [12], where initial implementation resulted in 14.3% invalid results. However, this resolved as users became more familiar with oral-fluid-based HIVST. Therefore, perhaps one way to reduce the numbers of invalid results with blood-based HIVST might be to provide additional support and training during early-stage implementation and then scale down over time.

This study adds to the growing literature around evaluations of preferences for HIV testing in sub-Saharan Africa. When given a choice between blood-based and oral fluid-based HIVST, 61% and 39% opted for oral-fluid-based HIVST compared to blood-based self-testing, respectively. An observational study conducted in Zimbabwe among different populations also found high preference of oral-fluid-based to blood-based HIVST (50% vs. 35%, respectively) [29]. Collectively, these findings buttress recommendations to increase choice of testing modalities to enhance HIV testing acceptability and uptake [32,33,34]. Importantly, men (hard-to-reach) were more likely to opt for blood-based HIVST. Considering the need to prioritise testing in this group [29, 35], it appears important to offer this option to promote greater access to and uptake of testing, which is essential to achieve global testing and treatment targets [22].

Increasing preference for oral-fluid-based to blood-based HIVST is linked to perceptions of the two procedures. In this study, over three-quarters (77%) thought oral-fluid-based HIVST was easier to conduct. This concurs with findings from the Zimbabwean study where participants perceived oral-fluid-based HIVST to be both less invasive and painless [29]. An interesting pattern continues to be observed among those that choose blood-based HIVST over oral-fluid-based HIVST. As found elsewhere [29], we found that (in Malawi) these participants are more likely to be urban, literate and earning a regular salary, with their main motivation being “to try new technologies”. As different HIV testing approaches are preferred by different groups, this highlights once again, the need to provide more choices [32,33,34].

Of note, doubts over the accuracy of oral-fluid-based HIVST found in this and other studies [27, 29], need to be appropriately addressed to enhance acceptability and uptake of this testing modality.

Findings on preferences for the “next test” are likely to be helpful in informing scale-up of HIVST going forward. The least preferred options included any testing involving a provider, regardless of venue. Men are especially concerned about being tested at a facility and deductive disclosure occurring in the event they are positive [36, 37]. HIVST provision should therefore be sensitive to various groups and individuals’ concerns and continue to ensure privacy [35, 38]. Following testing, some participants reportedly linked to post-test services (VMMC and HIV care), highlighting once again how testing is an entry point into HIV prevention, treatment, care and support services [4, 39, 40].

A strength of this cross-sectional study is that it explored preferences for several HIV testing modalities and among different settings. Also, we had equal numbers attending urban and rural health-care facilities. The study therefore provided a balanced range of perspectives. A potential limitation is that we did not explore in-depth some of the study findings (e.g. qualitatively), which would have provided context and nuances. Additionally, we made a conservative estimate (N = 1100) of the number of people who may have presented to the health facilities from which we recruited. Therefore, it is possible that the true number of eligible people may exceed the 709 that we reported here but the results are representative of the patient population. It is worth pointing out that this response rate of 64% may be considered low.

Lastly, many factors may motivate choice and preference. Therefore, choice at one point in time does not necessarily reflect overall preference, especially among those who have not been exposed to all options available [29].


This cross-sectional study enabled us to explore the accuracy of and preferences for oral-fluid vs. blood-based HIVST. Both types of self-testing achieved acceptable levels of accuracy and blood-based achieved almost complete accuracy. Both oral-fluid and blood-based HIVST are preferred over provider-delivered testing. Patterns of preference were observed whereby women, those not receiving a regular salary and participants attending rural facilities were more likely to opt for oral-fluid-based HIVST. Such information is helpful for HIVST programme policy makers who should be aware of specific groups’ behaviours/preferences when planning procurement at the population level.

Efforts to optimise implementation of blood-based HIVST are needed. Additional support and training may help to achieve optimal performance, especially during the initial stages of implementation, in which efforts to expedite familiarity with the procedure may help to reduce the frequency of invalid results more rapidly. Study findings are relevant to all programmes, ministries and implementers involved in scaling up HIVST.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. HIV self-testing data cannot be shared.



Blood-based self-testing


Confidence Interval


Human Immunodeficiency Virus


HIV self-testing


Oral-fluid-based self-testing


Structured Query Language


Voluntary medical male circumcision


  1. UNAIDS. Understanding Fast-Track: Accelerating Action to End the AIDS Epidemic by 2030. Geneva: UNAIDS; 2015.

    Google Scholar 

  2. WHO. Consolidated guidelines on HIV testing services. Geneva: World Health Organisation; 2019.

    Google Scholar 

  3. Eshun-Wilson I, Jamil MS, Witzel TC, Glidded DV, Johnson C, Le Trouneau N, Ford N, McGee K, Kemp C, Baral S, et al. A systematic review and network meta-analyses to assess the effectiveness of Human Immunodeficiency Virus (HIV) self-testing distribution strategies. Clin Infect Dis. 2021;73(4):e1018–28.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Jamil MS, Eshun-Wilson I, Witzel TC, Siegfried N, Figueroa C, Chitembo L, Msimanga-Radebe B, Pasha MS, Hatzold K, Corbett E, et al. Examining the effects of HIV self-testing compared to standard HIV testing services in the general population: a systematic review and meta-analysis. EClinicalMedicine. 2021;38:100991.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kiptinness C, Kuo AP, Reedy AM, Johnson CC, Ngure K, Wagner AD, Ortblad KF. Examining the use of HIV self-testing to support PrEP delivery: a systematic literature review. Curr HIV/AIDS Rep. 2022;19(5):394–408.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Gupta-Wright A, Barnabas RV, Ingold H, Duneton P, Abubakar I. HIV self-testing: lessons learnt and priorities for adaptation in a shifting landscape. BMJ Glob Health. 2021;6(Suppl 4):e004418.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ingold H, Mwerinde O, Ross AL, Leach R, Corbett EL, Hatzold K, Johnson CC, Ncube G, Nyirenda R, Baggaley RC. The Self-Testing AfRica (STAR) Initiative: accelerating global access and scale-up of HIV self-testing. J Int AIDS Soc. 2019;22(Suppl 1):e25249.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Asiimwe S, Oloya J, Song X, Whalen CC. Accuracy of un-supervised versus provider-supervised self-administered HIV testing in Uganda: a randomized implementation trial. AIDS Behav. 2014;18(12):2477–84.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Bwana P, Ochieng L, Mwau M. Performance and usability evaluation of the INSTI HIV self-test in Kenya for qualitative detection of antibodies to HIV. PLoS ONE. 2018;13(9):e0202491.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Choko AT, Desmond N, Webb EL, Chavula K, Napierala-Mavedzenge S, Gaydos CA, Makombe SD, Chunda T, Squire SB, French N, et al. The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi. PLoS Med. 2011;8(10):e1001102.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Choko AT, MacPherson P, Webb EL, Willey BA, Feasy H, Sambakunsi R, Mdolo A, Makombe SD, Desmond N, Hayes R, et al. Uptake, accuracy, safety, and linkage into care over two years of promoting annual self-testing for HIV in Blantyre, Malawi: a community-based prospective study. PLoS Med. 2015;12(9):e1001873.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kurth AE, Cleland CM, Chhun N, Sidle JE, Were E, Naanyu V, Emonyi W, Macharia SM, Sang E, Siika AM. Accuracy and acceptability of oral fluid HIV self-testing in a general adult population in Kenya. AIDS Behav. 2016;20(4):870–9.

    Article  PubMed  Google Scholar 

  13. Lee VJ, Tan SC, Earnest A, Seong PS, Tan HH, Leo YS. User acceptability and feasibility of self-testing with HIV rapid tests. J Acquir Immune Defic Syndr. 2007;45(4):449–53.

    Article  PubMed  Google Scholar 

  14. Lippman SA, Moran L, Sevelius J, Castillo LS, Ventura A, Treves-Kagan S, Buchbinder S. Acceptability and feasibility of HIV self-testing among transgender women in San Francisco: a mixed methods pilot study. AIDS Behav. 2016;20(4):928–38.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Mantell JE, Khalifa A, Christian SN, Romo ML, Mwai E, George G, Strauss M, Govender K, Kelvin EA. Preferences, beliefs, and attitudes about oral fluid and blood-based HIV self-testing among truck drivers in Kenya choosing not to test for HIV. Front Public Health. 2022;10:911932.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Neuman M, Mwinga A, Kapaku K, Sigande L, Gotsche C, Taegtmeyer M, Dacombe R, Maluzi K, Kosloff B, Johnson C, et al. Sensitivity and specificity of OraQuick(R) HIV self-test compared to a 4th generation laboratory reference standard algorithm in urban and rural Zambia. BMC Infect Dis. 2022;22(Suppl 1):494.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ngoc BV, Majam M, Green K, Tran T, Hung MT, Que AL, Ngoc DB, Le Duy CH. Acceptability, feasibility, and accuracy of blood-based HIV self-testing: a cross-sectional study in Ho Chi Minh City Vietnam. PLOS Glob Public Health. 2023;3(2):e0001438.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Tao J, Li MY, Qian HZ, Wang LJ, Zhang Z, Ding HF, Ji YC, Li DL, Xiao D, Hazlitt M, et al. Home-based HIV testing for men who have sex with men in China: a novel community-based partnership to complement government programs. PLoS ONE. 2014;9(7):e102812.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Tonen-Wolyec S, Djang’eing’a RM, Batina-Agasa S, Kayembe Tshilumba C, Muwonga Masidi J, Hayette MP, Belec L. Self-testing for HIV, HBV, and HCV using finger-stick whole-blood multiplex immunochromatographic rapid test: A pilot feasibility study in sub-Saharan Africa. PLoS ONE. 2021;16(4):e0249701.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Tonen-Wolyec S, Sarassoro A, Muwonga Masidi J, Twite Banza E, Nsiku Dikumbwa G, Maseke Matondo DM, Kilundu A, Kamanga Lukusa L, Batina-Agasa S, Belec L. Field evaluation of capillary blood and oral-fluid HIV self-tests in the Democratic Republic of the Congo. PLoS ONE. 2020;15(10):e0239607.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Volk JE, Lippman SA, Grinsztejn B, Lama JR, Fernandes NM, Gonzales P, Hessol NA, Buchbinder S. Acceptability and feasibility of HIV self-testing among men who have sex with men in Peru and Brazil. Int J STD AIDS. 2016;27(7):531–6.

    Article  PubMed  Google Scholar 

  22. UNAIDS: The path that ends AIDS: UNAIDS Global AIDS Update 2023. In.: Joint United Nations Programme on HIV/AIDS; 2023.

  23. UNAIDS: Laws and Policies Analytics. In., vol.; 2022.

  24. Indravudh PP, Choko AT, Corbett EL. Scaling up HIV self-testing in sub-Saharan Africa: a review of technology, policy and evidence. Curr Opin Infect Dis. 2018;31(1):14–24.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Figueroa C, Johnson C, Ford N, Sands A, Dalal S, Meurant R, Prat I, Hatzold K, Urassa W, Baggaley R. Reliability of HIV rapid diagnostic tests for self-testing compared with testing by health-care workers: a systematic review and meta-analysis. Lancet HIV. 2018;5(6):e277–90.

    Article  PubMed  PubMed Central  Google Scholar 

  26. WHO: Prequalified In Vitro Diagnostics. In., vol.; 2023.

  27. Kumwenda MK, Mavhu W, Lora WS, Chilongosi R, Sikwesese S, Taegtmeyer M, Hatzold K, Johnson CC, Corbett EL, Desmond N. Feasibility and acceptability of a peer-led HIV self-testing model among female sex workers in Malawi: a qualitative study. BMJ Open. 2021;11:e049248.

    Article  PubMed Central  Google Scholar 

  28. Napierala S, Desmond NA, Kumwenda MK, Tumushime M, Sibanda EL, Indravudh P, Hatzold K, Johnson CC, Baggaley RC, Corbett L, et al. HIV self-testing services for female sex workers, Malawi and Zimbabwe. Bull World Health Organ. 2019;97(11):764–76.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Mavhu W, Makamba M, Hatzold K, Maringwa G, Takaruza A, Mutseta M, Ncube G, Cowan FM, Sibanda EL. Preferences for oral-fluid-based or blood-based HIV self-testing and provider-delivered testing: an observational study among different populations in Zimbabwe. BMC Infect Dis. 2023;22(Suppl 1):973.

    Article  PubMed  PubMed Central  Google Scholar 

  30. O’Connell RJ, Merritt TM, Malia JA, VanCott TC, Dolan MJ, Zahwa H, Bradley WP, Branson BM, Michael NL, De Witt CC. Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol. 2003;41(5):2153–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Lora WS, Desmond N, Obasi A, Kumwenda M, Taegtmeyer M, Tolhurst R, MacPherson EE. “I wanted evidence that my status had changed, so that is why I tested”: experiences with HIV self-testing among female sex workers in Malawi. AIDS Care. 2020;32(sup2):206–13.

    Article  PubMed  Google Scholar 

  32. Celum C, Barnabas R. Reaching the 90–90-90 target: lessons from HIV self-testing. Lancet HIV. 2019;6(2):e68–9.

    Article  PubMed  Google Scholar 

  33. Kelvin EA, Akasreku B. The evidence for HIV self-testing to increase HIV testing rates and the implementation challenges that remain. Curr HIV/AIDS Rep. 2020;17(4):281–9.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Sibanda EL, d’Elbee M, Maringwa G, Ruhode N, Tumushime M, Madanhire C, Ong JJ, Indravudh P, Watadzaushe C, Johnson CC, et al. Applying user preferences to optimize the contribution of HIV self-testing to reaching the “first 90” target of UNAIDS Fast-track strategy: results from discrete choice experiments in Zimbabwe. J Int AIDS Soc. 2019;22(Suppl Suppl 1):e25245.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Hatzold K, Gudukeya S, Mutseta MN, Chilongosi R, Nalubamba M, Nkhoma C, Munkombwe H, Munjoma M, Mkandawire P, Mabhunu V, et al. HIV self-testing: breaking the barriers to uptake of testing among men and adolescents in sub-Saharan Africa, experiences from STAR demonstration projects in Malawi, Zambia and Zimbabwe. J Int AIDS Soc. 2019;22(Suppl Suppl 1):e25244.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Hatzold K, Mavhu W, Jasi P, Chatora K, Cowan FM, Taruberekera N, Mugurungi O, Ahanda K, Njeuhmeli E. Barriers and motivators to voluntary medical male circumcision uptake among different age groups of men in Zimbabwe: results from a mixed methods study. PLoS ONE. 2014;9(5):e85051.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Sibanda EL, Mavhu W. Secondary HIV self-test distribution increases male partner testing. Lancet Glob Health. 2021;9(12):e1632–3.

    Article  CAS  PubMed  Google Scholar 

  38. Choko AT, Corbett EL, Stallard N, Maheswaran H, Lepine A, Johnson CC, Sakala D, Kalua T, Kumwenda M, Hayes R, et al. HIV self-testing alone or with additional interventions, including financial incentives, and linkage to care or prevention among male partners of antenatal care clinic attendees in Malawi: an adaptive multi-arm, multi-stage cluster randomised trial. PLoS Med. 2019;16(1):e1002719.

    Article  PubMed  PubMed Central  Google Scholar 

  39. UNAIDS: Live life positively — Know your HIV status. In. Geneva: Joint United Nations Programme on HIV/AIDS; 2018.

  40. Sibanda E, Taegtmeyer M. Inequalities in uptake of HIV testing despite scale-up. Lancet Glob Health. 2020;8(6):e744-745.

    Article  PubMed  Google Scholar 

Download references


The authors would like to thank the HIV testing services clients who made the study possible.

About this supplement

This article has been published as part of BMC Infectious Diseases Volume 22 Supplement 1 2021: Innovating with HIV self-testing for impact in southern Africa: Lessons learned from the STAR (Self-Testing AfRica) Initiative. The full contents of the supplement are available at


Unitaid. Unitaid is a hosted partnership of the WHO. The funder had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

Author information

Authors and Affiliations



ELC, KH, AC, MKK, GS led the study design, with involvement from MN, CCJ and PI. ELC, KH, AC and MKK conceived and designed the study protocol. MKK, AC and GS led the study implementation and data collection. AOR, AC and MN carried out the statistical analysis. AOR, AC, MN and WM led data interpretation with involvement from CCJ and ELC. AOR, AC, WM and ELC wrote the paper and all authors were involved in the review of drafts. All authors have approved the final manuscript.

Corresponding author

Correspondence to Ailva O’Reilly.

Ethics declarations

Ethics approval and consent to participate

Ethical approval was granted by the Malawi College of Medicine Research Ethics Committee (#P.06/17/2197) and London School of Hygiene & Tropical Medicine Ethics Committee (#14267). All participants provided written (or witnessed if illiterate) informed consent.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests. The views expressed in this manuscript are those of the authors and do not necessarily represent the official position of the WHO.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Reilly, A., Mavhu, W., Neuman, M. et al. Accuracy of and preferences for blood-based versus oral-fluid-based HIV self-testing in Malawi: a cross-sectional study. BMC Infect Dis 22 (Suppl 1), 979 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: